Clinical Trial Information
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients with Modertately to Severely Active Ulcerative Colitis- Protocol Number: 12303
- Status: Open
- Treatment Type: Treatment
- Phase: III
- NCT ID: NCT03519945
Scope Information
- Disease Site(s):
- Other